(Q44376347)

2 December 2017

1 reference

title

Pharmacological treatment of post-traumatic behavioural disorders (English)

1 reference

2 December 2017

Richard I

1

1 reference

2 December 2017

Perrouin-Verbe B

2

1 reference

2 December 2017

Rome J

3

1 reference

2 December 2017

Bernat C

4

1 reference

2 December 2017

Mathé JF

5

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique

2 December 2017

published in

1 reference

2 December 2017

volume

46

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

49-57

1 reference

Carbamazepine clinical pharmacology: a review

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Reduction of severe aggressive behaviour in acquired brain injury: case studies illustrating clinical use of the OAS-MNR in the management of challenging behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The use of lithium in the treatment of aggressive behaviours with two brain-injured individuals in a state psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

A case of organic brain syndrome following head injury successfully treated with carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Personality and behavioural change after severe blunt head injury--a relative's view

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Factor structure of the Agitated Behavior Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Lamotrigine and gabapentin. Alternative in the treatment of bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Definition of agitation following traumatic brain injury: I. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Measurement and treatment of agitation following traumatic brain injury: II. A survey of the Brain Injury Special Interest Group of the American Academy of Physical Medicine and Rehabilitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Prescribing of potentially harmful drugs to patients admitted to hospital after head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Risperidone for treating dementia-associated aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Methylphenidate effect on attention deficit in the acutely brain-injured adult

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Neuropsychiatric sequelae of stroke and traumatic brain injury: the role of psychostimulants.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Buspirone and agitation in head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Successful treatment of episodic dyscontrol with carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Methotrimeprazine in the treatment of agitation in acquired brain injury patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Long-term neuropsychological outcome and loss of social autonomy after traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Sodium valproate in the treatment of behavioral disturbance in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The agitated brain injured patient. Part 2: Pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Improved arousal and initiation following tricyclic antidepressant use in severe brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Organic catatonia following frontal lobe injury: response to clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The agitated brain injured patient. Part 1: Definitions, differential diagnosis, and assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Panic disorder in a patient with traumatic brain injury: a case report and discussion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

A metaanalysis of controlled trials of neuroleptic treatment in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Selective serotonin reuptake inhibitor treatment of post-traumatic Klüver-Bucy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

A double-blind controlled study of methylphenidate treatment in closed head injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Cognitive effects of antipsychotic agents in persons with traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Anticonvulsant and other non-neuroleptic treatment of agitation in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The use of bupropion in the treatment of restlessness after a traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Intramuscular midazolam for treatment of acute seizures or behavioral episodes in patients with brain injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

The Overt Aggression Scale for the objective rating of verbal and physical aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-6054%2802%2900353-7

7 January 2021

10.1016/S0168-6054(02)00353-7

Identifiers

DOI

1 reference

2 December 2017

1 reference